acacia_10q-093009.htm
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
10-Q
Mark
One
x QUARTERLY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE
QUARTERLY PERIOD ENDED SEPTEMBER 30, 2009
or
o TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
FOR THE
TRANSITION PERIOD FROM
TO
Commission
File Number: 0-26068
ACACIA
RESEARCH CORPORATION
(Exact
name of registrant as specified in its charter)
DELAWARE
|
95-4405754
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
500
Newport Center Drive, Newport Beach, California 92660
(Address
of principal executive offices)
(949)
480-8300
(Registrant’s
telephone number, including area code)
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. x Yes o No
Indicate
by check mark whether the registrant has submitted electronically and posted on
its corporate Web site, if any, every Interactive Data File required to be
submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such
files). o Yes o No
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act:
Large
accelerated filer o
|
Accelerated
filer x
|
Non-accelerated
filer o (Do not check if
a smaller reporting company)
|
Smaller reporting company o
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes o No x
As of
November 3, 2009, 31,852,066 shares of the registrant’s common stock, $0.001 par
value, were issued and outstanding.
ACACIA
RESEARCH CORPORATION
Table
of Contents
Part
I. Financial Information
|
|
|
|
|
|
|
|
Item
1.
|
Financial
Statements
|
|
|
|
|
|
Consolidated Balance Sheets as of
September 30, 2009 and
December 31, 2008
(Unaudited)
|
1
|
|
|
|
|
Consolidated Statements of
Operations for the Three Months and Nine Months
Ended September 30, 2009 and 2008
(Unaudited)
|
2
|
|
|
|
|
Consolidated Statements of Cash
Flows for the Nine Months Ended
September 30, 2009 and 2008
(Unaudited)
|
3
|
|
|
|
|
Notes to Consolidated Financial
Statements (Unaudited)
|
4
|
|
|
|
|
|
|
Item
2.
|
Management’s Discussion and
Analysis of Financial Condition and
Results of Operations
|
11
|
|
|
|
Item
3.
|
Quantitative and Qualitative
Disclosures About Market Risk
|
21
|
|
|
|
Item
4.
|
Controls and Procedures
|
21
|
|
|
|
|
|
|
|
|
|
|
|
|
Part
II. Other Information
|
|
|
|
|
|
|
|
Item
6.
|
Exhibits
|
21
|
|
|
|
|
|
|
Signatures
|
22
|
|
|
Exhibit Index
|
23
|
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(In
thousands, except share and per share information)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September
30,
|
|
|
December
31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$ |
42,800 |
|
|
$ |
48,279 |
|
Accounts
receivable
|
|
|
6,535 |
|
|
|
7,436 |
|
Deferred
royalties and contingent legal fees
|
|
|
2,398 |
|
|
|
- |
|
Prepaid
expenses and other current assets
|
|
|
1,512 |
|
|
|
1,255 |
|
Total
current assets
|
|
|
53,245 |
|
|
|
56,970 |
|
|
|
|
|
|
|
|
|
|
Property
and equipment, net of accumulated depreciation
|
|
|
186 |
|
|
|
221 |
|
Patents,
net of accumulated amortization
|
|
|
18,211 |
|
|
|
12,419 |
|
Investments
- noncurrent
|
|
|
2,484 |
|
|
|
3,239 |
|
Other
assets
|
|
|
1,948 |
|
|
|
225 |
|
|
|
$ |
76,074 |
|
|
$ |
73,074 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts
payable and accrued expenses
|
|
$ |
5,766 |
|
|
$ |
3,240 |
|
Royalties
and contingent legal fees payable
|
|
|
8,733 |
|
|
|
10,770 |
|
Deferred
revenues
|
|
|
4,580 |
|
|
|
318 |
|
Total
current liabilities
|
|
|
19,079 |
|
|
|
14,328 |
|
|
|
|
|
|
|
|
|
|
Deferred
revenues, net of current portion
|
|
|
2,402 |
|
|
|
- |
|
Other
liabilities
|
|
|
246 |
|
|
|
199 |
|
Total
liabilities
|
|
|
21,727 |
|
|
|
14,527 |
|
|
|
|
|
|
|
|
|
|
Commitments
and contingencies (Note 6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Acacia
Research Corporation stockholders' equity:
|
|
|
|
|
|
|
|
|
Preferred
stock, par value $0.001 per share; 10,000,000
|
|
|
|
|
|
|
|
|
shares
authorized; no shares issued or outstanding
|
|
|
- |
|
|
|
- |
|
Common
stock, par value $0.001 per share; 100,000,000 shares
|
|
|
|
|
|
|
|
|
authorized;
31,839,066 and 30,884,994 shares issued and outstanding
|
|
|
|
|
|
|
|
|
as
of September 30, 2009 and December 31, 2008, respectively
|
|
|
32 |
|
|
|
31 |
|
Additional
paid-in capital
|
|
|
172,018 |
|
|
|
167,468 |
|
Accumulated
deficit
|
|
|
(118,732 |
) |
|
|
(108,952 |
) |
Total
Acacia Research Corporation stockholders' equity
|
|
|
53,318 |
|
|
|
58,547 |
|
|
|
|
|
|
|
|
|
|
Noncontrolling
interests in operating subsidiary
|
|
|
1,029 |
|
|
|
- |
|
Total
stockholders' equity
|
|
|
54,347 |
|
|
|
58,547 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
76,074 |
|
|
$ |
73,074 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS
(In
thousands, except share and per share information)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For
the Three Months Ended
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
License
fee revenues
|
|
$ |
12,831 |
|
|
$ |
13,796 |
|
|
$ |
40,512 |
|
|
$ |
29,960 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventor
royalties
|
|
|
3,010 |
|
|
|
4,329 |
|
|
|
8,890 |
|
|
|
8,596 |
|
Contingent
legal fees
|
|
|
3,470 |
|
|
|
3,934 |
|
|
|
9,890 |
|
|
|
8,503 |
|
Legal
expenses - patents
|
|
|
3,536 |
|
|
|
1,110 |
|
|
|
7,000 |
|
|
|
3,111 |
|
Research,
consulting and other expenses - patents
|
|
|
404 |
|
|
|
444 |
|
|
|
1,350 |
|
|
|
1,555 |
|
Amortization
of patents
|
|
|
1,245 |
|
|
|
1,152 |
|
|
|
3,370 |
|
|
|
3,731 |
|
Marketing,
general and administrative expenses (including non-cash stock compensation
expense
of $1,472 and $5,573 for the three and nine months ended September 30,
2009, respectively and
$1,949 and $5,716 for the three and nine months ended September 30, 2008,
respectively)
|
|
|
5,089 |
|
|
|
5,464 |
|
|
|
17,076 |
|
|
|
17,014 |
|
Total
operating costs and expenses
|
|
|
16,754 |
|
|
|
16,433 |
|
|
|
47,576 |
|
|
|
42,510 |
|
Operating
loss
|
|
|
(3,923 |
) |
|
|
(2,637 |
) |
|
|
(7,064 |
) |
|
|
(12,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
income
|
|
|
23 |
|
|
|
242 |
|
|
|
122 |
|
|
|
935 |
|
Gain
on foreign currency translation
|
|
|
- |
|
|
|
- |
|
|
|
201 |
|
|
|
- |
|
Gain
(loss) on investments
|
|
|
201 |
|
|
|
13 |
|
|
|
235 |
|
|
|
(250 |
) |
Total
other income
|
|
|
224 |
|
|
|
255 |
|
|
|
558 |
|
|
|
685 |
|
Loss
from operations before provision for income taxes
|
|
|
(3,699 |
) |
|
|
(2,382 |
) |
|
|
(6,506 |
) |
|
|
(11,865 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision
for income taxes
|
|
|
(47 |
) |
|
|
(38 |
) |
|
|
(124 |
) |
|
|
(85 |
) |
Net
loss including noncontrolling interests in operating
subsidiary
|
|
|
(3,746 |
) |
|
|
(2,420 |
) |
|
|
(6,630 |
) |
|
|
(11,950 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income attributable to noncontrolling interests in operating
subsidiary
|
|
|
(1,029 |
) |
|
|
- |
|
|
|
(3,150 |
) |
|
|
- |
|
Net
loss attributable to Acacia Research Corporation
|
|
$ |
(4,775 |
) |
|
$ |
(2,420 |
) |
|
$ |
(9,780 |
) |
|
$ |
(11,950 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss per common share attributable to Acacia Research
Corporation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted net loss per share
|
|
$ |
(0.16 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.33 |
) |
|
$ |
(0.41 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
average number of shares outstanding, basic and diluted
|
|
|
30,071,492 |
|
|
|
29,553,609 |
|
|
|
29,818,956 |
|
|
|
29,365,035 |
|
The
accompanying notes are an integral part of these consolidated financial
statements.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(In
thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
loss including noncontrolling interests in operating
subsidiary
|
|
$
|
(6,630
|
)
|
|
$
|
(11,950
|
)
|
Adjustments
to reconcile net loss including noncontrolling interests in operating
subsidiary to net cash provided by (used in) operating activities
:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
3,465
|
|
|
|
3,830
|
|
Non-cash
stock compensation
|
|
|
5,573
|
|
|
|
5,716
|
|
(Gain)
loss on investments
|
|
|
(235
|
)
|
|
|
250
|
|
Other
|
|
|
-
|
|
|
|
6
|
|
Changes
in assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
901
|
|
|
|
(9,057
|
)
|
Prepaid
expenses, deferred fees and other assets
|
|
|
(4,378
|
)
|
|
|
11
|
|
Accounts
payable and accrued expenses
|
|
|
2,573
|
|
|
|
(19
|
)
|
Royalties
and contingent legal fees payable
|
|
|
(2,037
|
)
|
|
|
6,901
|
|
Deferred
revenues
|
|
|
6,664
|
|
|
|
135
|
|
Net
cash provided by (used in) operating activities from continuing
operations
|
|
|
5,896
|
|
|
|
(4,177
|
)
|
Net
cash provided by operating activities from discontinued
operations
|
|
|
-
|
|
|
|
2
|
|
Net
cash provided by (used in) operating activities
|
|
|
5,896
|
|
|
|
(4,175
|
)
|
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchase
of property and equipment
|
|
|
(60
|
)
|
|
|
(28
|
)
|
Purchase
of available-for-sale investments
|
|
|
-
|
|
|
|
(265
|
)
|
Sale
of available-for-sale investments
|
|
|
990
|
|
|
|
6,328
|
|
Patent
acquisition costs
|
|
|
(9,162
|
)
|
|
|
(1,759
|
)
|
Net
cash provided by (used in) investing activities
|
|
|
(8,232
|
)
|
|
|
4,276
|
|
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Distributions
of noncontrolling interests in operating subsidiary
|
|
|
(2,121
|
)
|
|
|
-
|
|
Repurchased
restricted common stock
|
|
|
(1,107
|
)
|
|
|
-
|
|
Proceeds
from the exercise of stock options
|
|
|
85
|
|
|
|
142
|
|
Net
cash provided by (used in) financing activities
|
|
|
(3,143
|
)
|
|
|
142
|
|
|
|
|
|
|
|
|
|
|
Increase
(decrease) in cash and cash equivalents
|
|
|
(5,479
|
)
|
|
|
243
|
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents, beginning
|
|
|
48,279
|
|
|
|
40,467
|
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents, ending
|
|
$
|
42,800
|
|
|
$
|
40,710
|
|
The
accompanying notes are an integral part of these consolidated financial
statements.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. DESCRIPTION
OF BUSINESS AND BASIS OF PRESENTATION
Description of Business. As
used herein, “Acacia” and the “Company” refer to Acacia Research Corporation
and/or its wholly and majority-owned operating subsidiaries. All
intellectual property acquisition, development, licensing and enforcement
activities are conducted solely by certain of Acacia’s wholly and majority-owned
operating subsidiaries.
Acacia’s
operating subsidiaries acquire, develop, license and enforce patented
technologies. Acacia’s operating subsidiaries generate license fee
revenues and related cash flows from the granting of licenses for the use of
patented technologies that such operating subsidiaries own or
control. Acacia’s operating subsidiaries assist patent owners with
the prosecution and development of their patent portfolios, the protection of
their patented technologies from unauthorized use, the generation of licensing
revenue from users of their patented technologies and, if necessary, the
enforcement against unauthorized users of their patented technologies.
Currently, on a consolidated basis, Acacia’s operating subsidiaries own or
control the rights to over 125 patent portfolios, which include U.S. patents and
certain foreign counterparts, covering technologies used in a wide variety of
industries.
Basis of
Presentation. The accompanying Consolidated Financial
Statements include the accounts of Acacia and its wholly and majority-owned
operating subsidiaries. Intercompany transactions and balances have
been eliminated in consolidation.
Effective
January 1, 2009, Acacia adopted Financial Accounting Standards Board
("FASB") Accounting Standards Codification (“ASC”) Topic 810,
“Consolidation” (“ASC Topic 810”), on a prospective basis. ASC Topic
810 establishes accounting and reporting standards requiring the identification
of and distinction between ownership interests in subsidiaries held by the
parent and ownership interests in subsidiaries held by the noncontrolling
interest owners. ASC Topic 810 requires the noncontrolling interests in Acacia’s
majority-owned operating subsidiary to be separately presented as a component of
stockholders’ equity on the consolidated statement of financial position for the
applicable periods presented. In addition, ASC Topic 810 requires
that consolidated net income or loss be adjusted to include the net income or
loss attributed to the noncontrolling interests in the majority-owned operating
subsidiary on the consolidated statements of operations for the applicable
periods presented. Refer to the accompanying consolidated balance
sheet for noncontrolling interests in Acacia’s majority-owned operating
subsidiary as of September 30, 2009 and the accompany consolidated statements of
operation for the three and nine months ended September 30, 2009 for the net
income attributable to noncontrolling interests in Acacia’s majority-owned
operating subsidiary.
The
accompanying Consolidated Financial Statements have been prepared in accordance
with accounting principles generally accepted in the United States of America
for interim financial information and with the instructions to Form 10-Q and
Rule 10-01 of Regulation S-X. Accordingly, certain information and
footnotes required by accounting principles generally accepted in the United
States of America in annual financial statements have been omitted or condensed
in accordance with quarterly reporting requirements of the Securities and
Exchange Commission (“SEC”). These interim Consolidated Financial
Statements should be read in conjunction with the Consolidated Financial
Statements and notes thereto for the year ended December 31, 2008, as reported
by Acacia in its Annual Report on Form 10-K. The year-end
consolidated balance sheet data was derived from audited financial statements
but does not include all disclosures required by accounting principles generally
accepted in the United States of America.
The
Consolidated Financial Statements of Acacia include all adjustments of a normal
recurring nature which, in the opinion of management, are necessary for a fair
statement of Acacia’s financial position as of September 30, 2009, and results
of its operations and its cash flows for the interim periods
presented. The results of operations for the three and nine months
ended September 30, 2009 are not necessarily indicative of the results to be
expected for the entire fiscal year. Subsequent events were evaluated
for disclosure in these financial statements through November 2,
2009.
2. SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
Cost of
Revenues. Cost of revenues include the costs and expenses
incurred in connection with Acacia’s patent licensing and enforcement
activities, including inventor royalties paid to original patent owners,
contingent legal fees paid to external patent counsel, other patent-related
legal expenses paid to external patent counsel, licensing and enforcement
related research, consulting and other expenses paid to third parties and the
amortization of patent-related acquisition costs. These costs are
included under the caption “Cost of revenues” in the accompanying consolidated
statements of operations. Refer to Note 6 for additional information
regarding inventor royalties expenses and contingent legal fee
expenses.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Reclassifications. Certain
operating costs and expenses previously reported for the three and nine months
ended September 30, 2008 have been reclassified to conform with the current
period presentation.
Use of
Estimates. The preparation of financial statements in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the Consolidated Financial Statements and the
reported amounts of revenues and expenses during the reporting period. Actual
results could differ from these estimates.
Concentrations. Two licensees individually
accounted for 25% and 23% of license fee revenues recognized during the three
months ended September 30, 2009, and one licensee individually
accounted for 12% of license fee revenues recognized during the nine months
ended September 30, 2009. Two licensees individually
accounted for 43% and 11% of license fee revenues recognized during the three
months ended September 30, 2008, and one licensee individually
accounted for 20% of license fee revenues recognized during the nine months
ended September 30, 2008. Two licensees
individually represented approximately 61% and 15% of accounts receivable at
September 30, 2009. Three licensees individually represented approximately 27%,
24% and 19% of accounts receivable at December 31, 2008.
Stock-Based Compensation. The
compensation cost for all stock-based awards is measured at the grant date,
based on the fair value of the award, and is recognized as an expense in the
statements of operations, on a straight-line basis, over the employee’s
requisite service period (generally the vesting period of the equity award)
which is generally one to four years. The fair value of each option
award is estimated on the date of grant using a Black-Scholes option valuation
model. The fair value of restricted stock awards is determined by the
product of the number of shares granted and the grant date market price of the
underlying common stock. Stock-based compensation expense is recorded
only for those awards expected to vest using an estimated forfeiture
rate. Pre-vesting option forfeitures are estimated at the time of
grant and are reflected in stock-based compensation expense recognized in the
consolidated statements of operations.
Fair Value
Measurements. Effective January 1, 2008, Acacia adopted
ASC Topic 820, “Fair Value Measurements and Disclosures” (“ASC Topic
820”). ASC Topic 820 establishes a common definition for fair value
to be applied to U.S. generally accepted accounting principles guidance
requiring use of fair value, establishes a framework for measuring fair value,
and expands disclosure about such fair value measurements. The
adoption of ASC Topic 820 did not have a material impact on Acacia’s
consolidated financial position, results of operations and cash
flows.
ASC Topic
820 defines fair value as the price that would be received for an asset or the
exit price that would be paid to transfer a liability in the principal or most
advantageous market in an orderly transaction between market participants on the
measurement date and also establishes a fair value hierarchy which requires an
entity to maximize the use of observable inputs, where available. ASC
Topic 820 established a three-level hierarchy of valuation techniques used to
measure fair value, defined as follows:
|
·
|
Level
1 - Observable Inputs: Quoted prices in active markets for
identical investments;
|
|
·
|
Level
2 - Pricing Models with Significant Observable Inputs: Other
significant observable inputs, including quoted prices for similar
investments, interest rates, credit risk, etc.;
and
|
|
·
|
Level
3 - Unobservable Inputs: Significant unobservable inputs,
including the entity’s own assumptions in determining the fair value of
investments.
|
ASC Topic
820 requires the use of observable market inputs (quoted market prices) when
measuring fair value and requires a Level 1 quoted price to be used to measure
fair value whenever possible. Refer to Note 7 to these Consolidated
Financial Statements for information on the estimation of fair value for auction
rate securities held as of September 30, 2009.
Impairment of Marketable
Securities. Acacia
reviews impairments associated with its investments in marketable securities, if
any, to determine the classification of any impairment as “temporary” or
“other-than-temporary.” For investments classified as
available-for-sale, unrealized losses that are other than temporary are
recognized in the consolidated statements of operations. An
impairment is deemed other than temporary unless (a) Acacia has the ability and
intent to hold an investment for a period of time sufficient for recovery of its
carrying amount and (b) positive evidence indicating that the investment's
carrying amount is recoverable within a reasonable period of time outweighs any
evidence to the contrary. All available evidence, both positive and negative, is
considered to determine whether, based on the weight of that evidence, the
carrying amount of the investment is recoverable within a reasonable period of
time. Any recovery in fair value is not recorded in earnings until the security
is sold or otherwise disposed of. Refer to Note 7 to these
Consolidated Financial Statements for disclosures regarding investments in
auction rate securities.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Income
Taxes. Income taxes are accounted for using an asset and
liability approach that requires the recognition of deferred tax assets and
liabilities for the expected future tax consequences of events that have been
recognized in Acacia’s Consolidated Financial Statements or consolidated tax
returns. A valuation allowance is established to reduce deferred tax assets if
all, or some portion, of such assets will more than likely not be
realized. The tax provisions for the periods presented relate
primarily to state tax liabilities in jurisdictions where certain of Acacia’s
operating subsidiaries file separate state tax returns.
3. EARNINGS
PER SHARE
Earnings (Loss) Per
Share. Basic earnings per share is computed based upon the
weighted-average number of common shares outstanding, excluding unvested
restricted stock. Diluted earnings per share is computed based upon
the weighted-average number of common shares outstanding, including the dilutive
effect of common stock equivalents outstanding during the periods, using the
treasury stock method. Potentially dilutive common stock equivalents
primarily consist of employee stock options, unvested restricted stock, and
restricted stock units.
The
following table presents the weighted-average number of common shares
outstanding used in the calculation of basic and diluted loss per
share:
|
|
For
the Three Months Ended
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
and diluted weighted-average number of common shares
outstanding
|
|
|
30,071,492 |
|
|
|
29,553,609 |
|
|
|
29,818,956 |
|
|
|
29,365,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
outstanding stock options, nonvested restricted stock and restricted stock
units excluded from the computation
of diluted loss per share because the effect of inclusion would have been
anti-dilutive
|
|
|
5,341,165 |
|
|
|
6,054,677 |
|
|
|
5,341,165 |
|
|
|
6,054,677 |
|
4. PATENTS
Acacia’s
only identifiable intangible assets at September 30, 2009 and December 31, 2008,
are patents and patent rights. Patent-related accumulated
amortization totaled $24,543,000 and $21,173,000 as of September 30, 2009 and
December 31, 2008, respectively.
Acacia’s
patents and patent rights have remaining estimated economic useful lives ranging
from one to seven years. The weighted-average remaining estimated
economic useful life of Acacia’s patents and patent rights is five
years. Annual aggregate amortization expense is estimated to be
$1,255,000 for the remainder of 2009, $4,853,000 in 2010, $3,951,000 in 2011,
$2,247,000 in 2012 and $2,013,000 in 2013. At September 30, 2009 and
December 31, 2008, all acquired intangible assets were subject to
amortization.
For the
nine months ended September 30, 2009 and 2008, Acacia incurred patent / patent
rights acquisition costs totaling $9,162,000 and $1,759,000,
respectively. The patents and patent rights acquired have estimated
economic useful lives of approximately one to seven years.
5. DEFERRED
REVENUES AND RELATED ROYALTIES AND CONTINGENT LEGAL FEES
Deferred
license fee revenues, representing upfront license fee payments received or
receivable from licensees at the beginning of the contractual license term,
which are deferred and amortized in the statements of operations as license fee
revenues on a straight-line basis over the applicable license term, totaled
$6,982,000 at
September 30, 2009, compared to $318,000 at December 31,
2008. Related deferred royalties and contingent legal fees expense,
which are also amortized in the statement of operations on a straight-line basis
over the applicable license term, totaled $3,811,000 at September
30, 2009. The noncurrent portion of deferred royalties and contingent
legal fees, totaling $1,413,000 is included in “Other assets –
noncurrent.”
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
6. COMMITMENTS
AND CONTINGENCIES
Inventor
Royalties and Contingent Legal Expenses
In
connection with the acquisition of certain patents and patent rights, certain of
Acacia’s operating subsidiaries executed related agreements which grant to the
former owners of the respective patents or patent rights, the right to receive
inventor royalties based on future net license fee revenues (as defined in the
respective agreements) generated as a result of licensing the respective patents
or patent portfolios. Inventor royalties paid pursuant to the
agreements are expensed in the consolidated statements of operations in the
period that the related license fee revenues are recognized. In
certain instances, pursuant to the terms of the underlying inventor agreements,
costs paid by Acacia’s operating subsidiaries to acquire patents are recoverable
from future net revenues. Patent acquisition costs that are
recoverable from future net revenues are amortized over the estimated economic
useful life of the related patents, or as the prepaid royalties are earned by
the inventor, as appropriate, and the related expense is included in
amortization expense in the consolidated statements of
operations. Any unamortized patent acquisition costs recovered from
net revenues are expensed in the period recovered, and included in amortization
expense in the consolidated statements of operations.
Acacia’s
operating subsidiaries may retain the services of law firms that specialize in
intellectual property licensing and enforcement and patent law in connection
with their licensing and enforcement activities. These law firms may
be retained on a contingent fee basis whereby such law firms are paid on a
scaled percentage of any negotiated license fees, settlements or judgments
awarded based on how and when the license fees, settlements or judgments are
obtained. In instances where there are no recoveries from potential
infringers (i.e. license fees), no contingent legal fees are paid; however,
Acacia’s operating subsidiaries may be liable for certain out of pocket legal
costs incurred pursuant to the underlying legal services
agreement. Legal fees advanced by contingent law firms that are
required to be paid in the event that no license recoveries are obtained are
expensed as incurred and included in liabilities in the consolidated balance
sheets.
Patent
Enforcement and Other Litigation
Acacia is
subject to claims, counterclaims and legal actions that arise in the ordinary
course of business. Management believes that the ultimate liability
with respect to these claims and legal actions, if any, will not have a material
effect on Acacia’s consolidated financial position, results of operations or
cash flows. Certain of Acacia’s operating subsidiaries are often
required to engage in litigation to enforce their patents and patent
rights.
7. FAIR
VALUE MEASUREMENTS AND AUCTION RATE SECURITIES
As of
September 30, 2009, Acacia held investment grade auction rate securities with a
par value totaling $2,735,000. Acacia’s auction rate securities primarily
consist of auction rate investments backed by student loans, issued under
programs such as the Federal Family Education Loan Program, and high credit
quality securities issued by closed-end investment companies. Auction
rate securities are classified as available-for-sale securities and reflected at
fair value.
Historically,
Acacia’s auction rate securities were recorded at cost, which approximated their
fair market value due to their variable interest rates, which typically reset
every 7 to 35 days, despite the long-term nature of their stated contractual
maturities. The Dutch auction process that resets the applicable interest
rate at predetermined calendar intervals is intended to provide liquidity to the
holder of auction rate securities by matching buyers and sellers within a market
context enabling the holder to gain immediate liquidity by selling such
interests at par or rolling over their investment. If there is an
imbalance between buyers and sellers, the risk of a failed auction
exists. Due to current liquidity issues in the
global credit and capital markets, these securities have continued to experience
failed auctions since February 2008. In the event of a failed
auction, the auction rate securities continue to pay interest at the maximum
contractual rate in accordance with their terms; however, Acacia may not be able
to access the par value of the invested funds until a future auction of these
investments is successful, the security is called by the issuer, or a buyer is
found outside of the auction process.
As a
result of failed auctions, there are no reliable current observable market
prices available for these auction rate securities for purposes of establishing
fair market value as of September 30, 2009. As a result, the fair
values of these securities are estimated utilizing an analysis of certain
unobservable inputs and by reference to a discounted cash flow analysis as of
September 30, 2009. These analyses considered, among other items, the
underlying structure of each security, the collateral underlying the security
investments, the creditworthiness of the counterparty, the present value of
future principal and contractual interest payments discounted at rates
considered to be reflective of current market conditions, consideration of the
probabilities of default, continued auction failure, or repurchase or redemption
at par for each period, and estimates of the time period over which liquidity
related issues will be resolved. Observable market data for
instruments with similar characteristics to Acacia’s auction rate securities was
also considered when possible.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
At
September 30, 2009, the par value of auction rate securities collateralized by
student loan portfolios totaled $2,685,000. Due to the estimate that
the market for these student loan collateralized instruments may take in excess
of twelve months to fully recover, Acacia has classified these investments as
noncurrent in the accompanying consolidated balance sheets. Further,
as a result of the analysis described above, Acacia recorded an
other-than-temporary loss of $263,000 in the statement of operations for the
three months ended June 30, 2008. As a result of partial redemptions
at par on certain of these auction rate securities subsequent to June 30, 2008,
Acacia recorded realized gains totaling $26,000, reflecting a partial recovery
of the other-than-temporary loss originally recorded on these
securities. As of September 30, 2009, the net other-than-temporary
loss on auction rate securities collateralized by student loan portfolios
totaled $237,000.
At
September 30, 2009, the par value of auction rate securities issued by high
credit quality closed-end investment companies totaled
$50,000. Acacia recorded an other-than-temporary loss on auction rate
securities issued by high credit quality closed-end investment companies of
$236,000 in the statement of operations for the three months ended December 31,
2008. As a result of partial redemptions at par on certain of these
auction rate securities during the nine months ended September 30, 2009, Acacia
recorded realized gains totaling $222,000, reflecting a partial recovery of the
other-than-temporary loss originally recorded on these securities. As
of September 30, 2009, the net other-than-temporary loss on auction rate
securities issued by high credit quality closed-end investment companies totaled
$14,000. The issuer of the remaining closed-end investment security
held by us as of September 30, 2009, with a par value of $50,000, has announced
the finalization of plans to redeem the remaining outstanding auction rate
security at par.
Assets
measured at fair value on a recurring basis at September 30, 2009 were as
follows (in thousands):
|
|
|
|
|
Fair
Value Measurements at Reporting Date Using:
|
|
|
|
Balance
at
September
30,
|
|
|
Quoted
Prices in Active Markets
For Identical Assets
|
|
|
Significant
Other
Observable
Inputs
|
|
|
Significant Unobservable Inputs
|
|
Description
|
|
2009
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auction
rate securities
|
|
$ |
2,484 |
|
|
|
- |
|
|
|
- |
|
|
$ |
2,484 |
|
As a
result of a change in market conditions, during the first quarter of 2008 Acacia
modified the valuation methodology for auction rate securities to include
consideration of the factors discussed above and reference to a discounted cash
flow analysis. Accordingly, these securities changed from Level 1 to
Level 3 within the hierarchy prescribed by ASC Topic 820 since the initial
adoption on January 1, 2008.
The
following table presents the assets measured at fair value on a recurring basis
using significant unobservable inputs (Level 3) for the interim periods
presented (in thousands):
|
|
For
the Three Months
|
|
|
For
the Nine Months
|
|
|
|
Ended
September 30,
|
|
|
Ended
September 30,
|
|
|
|
2009
|
|
|
2008
|
|
|
2009
|
|
|
2008
|
|
Auction rate
securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
balance as of July 1 and January 1, respectively
|
|
$ |
3,123 |
|
|
$ |
4,687 |
|
|
$ |
3,239 |
|
|
$ |
- |
|
Transfers
to Level 3
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
6,000 |
|
Total
gains or (losses) (realized or unrealized):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Included
in earnings – other income (expense)
|
|
|
201 |
|
|
|
13 |
|
|
|
235 |
|
|
|
(250 |
) |
Settlements
|
|
|
(840 |
) |
|
|
(50 |
) |
|
|
(990 |
) |
|
|
(1,100 |
) |
Ending
balance as of September 30
|
|
$ |
2,484 |
|
|
$ |
4,650 |
|
|
$ |
2,484 |
|
|
$ |
4,650 |
|
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
8. REPURCHASE
OF RESTRICTED COMMON STOCK
In May
2009, Acacia’s board of directors approved a restricted stock vesting net
issuance program. Under the program, upon the vesting of unvested
shares of restricted common stock, Acacia withheld from fully vested shares of
common stock otherwise deliverable to any employee-participant in Acacia’s
equity compensation programs, a number of whole shares of common stock having a
fair market value (as determined by Acacia as of the date of vesting) equal to
the amount of tax required to be withheld by law, in order to satisfy the tax
withholding obligations of Acacia in connection with the vesting of such
shares. Of a total of 580,600 shares of restricted stock vested in
June through September 2009, 174,628 shares of common stock were withheld by
Acacia, in satisfaction of $1,107,000 in required withholding tax
liability.
9. COMPREHENSIVE
LOSS
Total
comprehensive loss attributable to Acacia Research Corporation is as follows (in
thousands):
|
|
For
the Three Months Ended
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss including noncontrolling interests in operating
subsidiary
|
|
$ |
(3,746 |
) |
|
$ |
(2,420 |
) |
|
$ |
(6,630 |
) |
|
$ |
(11,950 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized
gain on short-term investments
|
|
|
- |
|
|
|
2 |
|
|
|
- |
|
|
|
3 |
|
Total
comprehensive loss before noncontrolling interests in operating
subsidiary
|
|
|
(3,746 |
) |
|
|
(2,418 |
) |
|
|
(6,630 |
) |
|
|
(11,947 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income attributable to noncontrolling interests in operating
subsidiary
|
|
|
(1,029 |
) |
|
|
- |
|
|
|
(3,150 |
) |
|
|
- |
|
Comprehensive
loss
|
|
$ |
(4,775 |
) |
|
$ |
(2,418 |
) |
|
$ |
(9,780 |
) |
|
$ |
(11,947 |
) |
10. RECENT
ACCOUNTING PRONOUNCEMENTS
In
October 2009, the FASB issued new accounting guidance related to the revenue
recognition of multiple element arrangements. The new guidance states
that if vendor specific objective evidence or third party evidence for
deliverables in an arrangement cannot be determined, companies will be required
to develop a best estimate of the selling price to separate deliverables and
allocate arrangement consideration using the relative selling price
method. The accounting guidance will be applied prospectively and
will become effective during the first quarter of 2011. Early
adoption is allowed. We are currently evaluating the impact of this
accounting guidance on Acacia’s Consolidated Financial Statements.
In
October 2009, the FASB issued new accounting guidance related to certain revenue
arrangements that include software elements. Previously, companies
that sold tangible products with “more than incidental” software were required
to apply software revenue recognition guidance. This guidance often
delayed revenue recognition for the delivery of the tangible
product. Under the new guidance, tangible products that have software
components that are “essential to the functionality” of the tangible product
will be excluded from the software revenue recognition guidance. The
new guidance is to be applied on a prospective basis for revenue arrangements
entered into or materially modified in fiscal years beginning on or after
June 15, 2010, with earlier application permitted. The adoption
of this accounting guidance will not have an impact on Acacia’s Consolidated
Financial Statements.
During
the third quarter of 2009, Acacia adopted the new Accounting Standards
Codification (ASC) as issued by the FASB. The ASC has become the
source of authoritative U.S. generally accepted accounting principles recognized
by the FASB to be applied by nongovernmental entities. The ASC is not
intended to change or alter existing U.S. generally accepted accounting
principles. The adoption of the ASC did not have a material impact on
Acacia’s Consolidated Financial Statements.
In August
2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-05,
“Fair Value Measurements and Disclosures (Topic 820) - Measuring Liabilities at
Fair Value.” This update provides clarification for the fair value
measurement of liabilities in circumstances in which a quoted price in an active
market for an identical liability is not available. This update is
effective for interim periods beginning after August 28,
2009. Acacia does not expect the adoption of this standard to have a
material effect on its financial position, results of operations or cash
flows.
In
June 2009, the FASB issued new accounting guidance related to accounting
for transfers of financial assets. The new guidance changes the
accounting for securitizations and special-purpose entities and enhances
disclosure requirements related to the transfers of financial assets, including
securitization transactions, and the continuing risk exposures related to
transferred financial assets. The new guidance also modifies the
criteria which determines whether an entity should be
consolidated. The accounting guidance will be effective for fiscal
years beginning after November 15, 2009. Acacia is currently
evaluating the impact the adoption of these standards will have on its
Consolidated Financial Statements and related disclosures.
ACACIA
RESEARCH CORPORATION AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
In June
2009, the FASB issued new accounting guidance which amends the evaluation
criteria to identify the primary beneficiary of a variable interest entity
(“VIE”) and requires ongoing reassessment of whether an enterprise is the
primary beneficiary of the VIE. The new guidance significantly
changes the consolidation rules for VIEs including the consolidation of common
structures, such as joint ventures, equity method investments and collaboration
arrangements. The guidance is applicable to all new and existing
VIEs. The provisions of this new accounting guidance is effective for
interim and annual reporting periods ending after November 15, 2009 and
will become effective for us beginning in the first quarter of
2010. Acacia does not expect the adoption of this accounting guidance
to have a material impact on its Consolidated Financial Statements and related
disclosures.
Item
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
Cautionary
Statement
You
should read the following discussion and analysis in conjunction with the
Consolidated Financial Statements and related notes thereto contained in Part I,
Item 1 of this Quarterly Report on Form 10-Q. The information contained in this
Quarterly Report on Form 10-Q is not a complete description of our business or
the risks associated with an investment in our common stock. We urge you to
carefully review and consider the various disclosures made by us in this report
and in our other reports filed with the Securities and Exchange Commission, or
the SEC, including our Annual Report on Form 10-K for the year ended December
31, 2008, filed with the SEC on February 26, 2009.
This
Quarterly Report on Form 10-Q contains forward-looking statements that have been
made pursuant to the “safe harbor” provisions of the Private Securities
Litigation Reform Act of 1995 and concern matters that involve risks and
uncertainties that could cause actual results to differ materially from those
projected in the forward-looking statements. Reference is made in particular to
the description of our plans and objectives for future operations, assumptions
underlying such plans and objectives, and other forward-looking statements set
forth under “Management’s Discussion and Analysis of Financial Condition and
Results of Operations” and other sections of this Quarterly Report on Form 10-Q.
Such statements may be identified by the use of forward-looking terminology such
as “may,” “will,” “should,” “could,” “expect,” “plan,” “believe,” “estimate,”
“anticipate,” “intend,” “predict,” “potential,” “continue,” or similar terms,
variations of such terms or the negative of such terms, although not all
forward-looking statements contain these terms. Such statements are based on
management’s current expectations and are subject to a number of factors and
uncertainties, which could cause actual results to differ materially from those
described in the forward-looking statements. Such statements address future
events and conditions concerning intellectual property acquisition and
development, licensing and enforcement activities, capital expenditures,
earnings, litigation, regulatory matters, markets for services, liquidity and
capital resources and accounting matters. Actual results in each case could
differ materially from those anticipated in such statements by reason of factors
such as future economic conditions, changes in demand for our services,
legislative, regulatory and competitive developments in markets in which we and
our subsidiaries operate, results of litigation and other circumstances
affecting anticipated revenues and costs. We expressly disclaim any intent,
obligation or undertaking to update or revise any forward-looking statements
contained herein to conform such statements to actual results or to reflect any
change in our expectations with regard thereto or any change in events,
conditions or circumstances on which any such statement is based. Readers are
urged to carefully review and consider the various disclosures made by us, which
attempt to advise interested parties of the risks, uncertainties, and other
factors that affect our business, including without limitation the disclosures
made under the captions “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and “Financial Statements” in this
Quarterly Report on Form 10-Q and the audited financial statements and the notes
thereto and disclosures made under the captions “Management Discussion and
Analysis of Financial Condition and Results of Operations,” “Risk Factors”
and “Financial Statements and Supplementary Data” included in our
Annual Report on Form 10-K for the year ended December 31, 2008.
General
As used
in this Quarterly Report on Form 10-Q, “we,” “us” and “our” refer to Acacia
Research Corporation, a Delaware corporation, and/or its wholly and
majority-owned operating subsidiaries. All intellectual property
acquisition, development, licensing and enforcement activities are conducted
solely by certain of Acacia Research Corporation’s wholly and majority-owned
operating subsidiaries.
Our
operating subsidiaries acquire, develop, license and enforce patented
technologies. Our operating subsidiaries generate license fee revenues and
related cash flows from the granting of licenses for the use of patented
technologies that our operating subsidiaries own or control. Our operating
subsidiaries assist patent owners with the prosecution and development of their
patent portfolios, the protection of their patented inventions from unauthorized
use, the generation of licensing revenue from users of their patented
technologies and, if necessary, with the enforcement against unauthorized users
of their patented technologies.
We are a
leader in licensing patented technologies and have established a proven track
record of licensing success with over 650 license agreements executed to date,
across 56 of our technology license programs. On a consolidated basis, our
operating subsidiaries own or control the rights to over 125 patent portfolios,
which include U.S. patents and certain foreign counterparts, covering
technologies used in a wide variety of industries.
We were
originally incorporated in California in January 1993 and reincorporated in
Delaware in December 1999.
Overview
Our
operating activities during the three and nine months ended September 30, 2009
and 2008 were principally focused on the continued development, licensing and
enforcement of the patent portfolios owned or controlled by our operating
subsidiaries, including the continued pursuit of multiple ongoing technology
licensing and enforcement programs and the commencement of new
technology licensing and enforcement programs. In addition, we
continued our focus on business development, including the acquisition of
several additional patent portfolios by certain of our operating subsidiaries
and the continued pursuit of additional opportunities to partner with patent
owners and continue our unique intellectual property licensing, development and
enforcement activities.
License
fee revenues recognized for the three months ended September 30, 2009 totaled
$12.8 million, as compared to $13.8 million for the three months ended September
30, 2008. License fee revenues recognized for the nine months ended
September 30, 2009 totaled $40.5 million, as compared to $30.0 million for the
nine months ended September 30, 2008.
Revenues
for the three and nine months ended September 30, 2009 included license fees
from 36 and 85, respectively, new licensing agreements covering 18 and 25,
respectively, of our technology licensing and enforcement
programs. During the nine months ended September 30, 2009 and 2008,
on a consolidated basis, our operating subsidiaries generated licensing revenues
from 8 and 15 new technology licensing and enforcement programs,
respectively. Revenues for the three and nine months ended September
30, 2008 included license fees from 20 and 60, respectively, new licensing
agreements covering 18 and 24, respectively, of our technology licensing and
enforcement programs. As of September 30, 2009, we have generated revenues from
56 technology licensing and enforcement programs, as compared to 48 programs as
of December 31, 2008, and 43 programs as of September 30, 2008.
During
the nine months ended September 30, 2009, we recorded initial license fee
revenues from 8 new technology licensing programs, including our Database Access
technology, Surgical Catheter technology, Encrypted Media & Playback Devices
technology, Child-friendly Secure Mobile Phones technology, Heated Surgical
Blades technology, Lighting Ballast technology, Microprocessor technology, and
our Online Promotion technology. Revenues for the nine months ended
September 30, 2009 also included fees from the licensing of our DMT® technology,
Telematics technology, Pop-up Internet Advertising technology, Audio
Communications Fraud Detection technology, Picture Archiving & Communication
Systems technology, Projector technology, Rule Based Monitoring technology,
Credit Card Fraud Protection technology, Remote Management of Imaging Devices
technology, Vehicle Maintenance technology, Medical Image
Stabilization technology, Audio Video Enhancement & Synchronization
technology, Location Based Services technology, eCommerce Pricing technology,
High Quality Image Processing technology, Storage technology and Online Auction
Guarantee technology.
During
the nine months ended September 30, 2008, we recorded initial license fee
revenues for 15 of our technology licensing programs, including our Vehicle
Anti-Theft Parking Systems technology, Online Auction Guarantee technology,
Projector technology, Web Personalization technology, Vehicle Maintenance
technology, Physical Access Control technology, High Resolution Optics
technology, Software License Management technology, Authorized Spending Accounts
technology, Picture Archiving & Communications System technology, Video
Editing technology, Electronic Message Advertising technology, Remote Management
of Imaging Devices technology, High Quality Image Processing technology and
Wireless Traffic Information technology. Eight of these licensing
programs generated initial revenues in the third quarter of
2008. Revenues for the nine months ended September 30, 2008 also
included fees from the licensing of our Audio Communications Fraud Detection
technology, Credit Card Fraud Protection technology, DMT® technology, Electronic
Address List Management technology, Image Resolution Enhancement technology,
Pop-up Internet Advertising technology, Portable Storage Devices with Links
technology, Rule-Based Monitoring technology and Telematics
technology.
Our
revenues historically have fluctuated quarterly based on the number of patented
technology portfolios owned or controlled by our operating subsidiaries, the
timing and results of patent filings and other enforcement proceedings relating
to our intellectual property rights, the number of active licensing programs,
and the relative maturity of active licensing programs during the applicable
periods. Additional factors impacting the amount of license fee
revenues recognized each period are included below.
We
measure and assess the performance and growth of the patent licensing and
enforcement business conducted by our operating subsidiaries based on
consolidated license fee revenues recognized across all of our technology
licensing and enforcement programs on a trailing twelve-month
basis. Trailing twelve-month revenues totaled $58.8 million as of
September 30, 2009, as compared to $59.7 million as of June 30, 2009, $51.8
million as of March 31, 2009, $48.2 million as of December 31, 2008, and $42.0
million as of September 30, 2008.
The
consolidated net loss for the three and nine months ended September 30, 2009 was
$4.8 million and $9.8 million, respectively, as compared to $2.4
million and $12.0 million, respectively, for the three and nine months ended
September 30, 2008. Results for the three and nine months ended
September 30, 2009 included non-cash charges totaling $2.7 million and $8.9
million, respectively, comprised of non-cash stock compensation charges of $1.5
million and $5.6 million, respectively and non-cash patent amortization charges
of $1.2 million and $3.4 million, respectively. Results for the
three and nine months ended September 30, 2008 included non-cash charges of $3.1
million and $9.4 million, respectively, comprised of non-cash stock compensation
charges of $1.9 million and $5.7 million, respectively, and non-cash patent
amortization charges of $1.2 million and $3.7 million,
respectively.
Marketing, general and administrative
expenses, including non-cash stock compensation charges, for the three and nine
months ended September 30, 2009 was $5.1 million and $17.1 million,
respectively, as compared to $5.5 million and $17.0 million, respectively, for
the three and nine months ended September 30, 2008. The decrease for the three
month period was primarily
due to a decrease in non-cash stock compensation charges resulting from a
reduction in personnel since the end of the prior year period and a decrease in
the average fair value of equity-based incentive awards expensed in the third
quarter of 2009, as compared to the prior year period. The decrease
was partially offset by a minor increase in general and administrative expenses
related to ongoing operations. The increase for the nine month period
was due primarily to an increase in business development related research and
consulting expenses, partially offset by a decrease in other corporate, general
and administrative costs related to ongoing operations and a decrease in noncash
stock compensation charges resulting from a reduction in personnel
since the end of the prior year period and a decrease in the average fair value
of equity-based incentive awards expensed during the nine months ended September
30, 2009, as compared to the prior year period.
In the
aggregate, inventor royalties, net income attributable to noncontrolling
interests in operating subsidiary and contingent legal fees expenses for the
three months ended September 30, 2009 decreased by 9%, as compared to the prior
year period, versus a decrease of 7% in related license fee revenues for the
same periods, as discussed above. In the aggregate, inventor royalties, net
income attributable to noncontrolling interests in operating subsidiary and
contingent legal fees expenses for the nine months ended September 30, 2009
increased by 28%, as compared to the prior year period, versus an increase of
35% in related license fee revenues for the same periods, as discussed
above.
Patent-related
legal expenses for the three months ended September 30, 2009 and 2008 were $3.5
million and $1.1 million, respectively. Patent-related legal expenses
for the nine months ended September 30, 2009 and 2008 were $7.0 million and $3.1
million, respectively. Patent-related legal expenses fluctuate from period to
period based on patent enforcement and prosecution activities associated with
ongoing licensing and enforcement programs and the timing of the commencement of
new licensing and enforcement programs in each period. Patent-related
legal expenses for the three and nine months ended September 30, 2009 increased
due to an increase in litigation support related out of pocket expenses, third
party technical consulting expenses and professional expert expenses incurred in
connection with our continued investment in certain of our licensing and
enforcement programs with trial dates scheduled for late 2009 and early 2010,
and a net increase in costs related to new licensing and enforcement programs
commenced since the end of the prior year period.
We expect
patent-related legal expenses to continue to fluctuate period to period based on
the factors summarized above, in connection with upcoming scheduled trial dates
and our current and future patent acquisition, development, licensing and
enforcement activities.
We pursue
enforcement actions in connection with our licensing and enforcement programs
which can involve certain risks and uncertainties, including the
following:
|
·
|
Increases
in patent-related legal expenses, including, but not limited to, increases
in costs billed by outside legal counsel for discovery, depositions,
economic analyses, damages assessments, expert witnesses and other
consultants, case-related audio/video presentations and other litigation
support and administrative costs, could increase our operating costs and
decrease our revenue generating
opportunities;
|
|
·
|
Our
patented technologies and enforcement actions are complex, and, as a
result, we may be required to appeal adverse decisions by trial courts in
order to successfully enforce our
patents;
|
|
·
|
New
legislation, regulations or rules related to enforcement actions could
significantly increase our operating costs and decrease our revenue
generating opportunities; and
|
|
·
|
Courts
may rule that our subsidiaries have violated certain statutory,
regulatory, federal, local or governing rules or standards by pursuing
such enforcement actions, which may expose us and our operating
subsidiaries to material liabilities, which could harm our operating
results and our financial position.
|
Investments
in Patent Portfolios
During
the three and nine months ended September 30, 2009, certain of our operating
subsidiaries continued to execute their business strategy in the area of patent
portfolio acquisitions. Patent portfolio acquisition costs for the
three months ended September 30, 2009 totaled $8.8 million, as compared to
$100,000 during the comparable 2008 period. Patent portfolio
acquisition costs for the nine months ended September 30, 2009 totaled $9.2
million, as compared to $1.8 million during the comparable 2008
period. The total number of patents, associated U.S. applications and
foreign counterparts per portfolio acquired during the three and nine months
ended September 30, 2009 ranged from one to 59. Several of the patent
portfolios acquired in the third quarter of 2009 were acquired in connection
with partnering arrangements executed with major technology companies,
reflecting our continued identification of opportunities to partner not only
with individual inventors and small to medium size technology companies, but
also major well established technology companies with larger patent
portfolios.
Of the
$9.2 million in patent acquisition costs invested during the nine months ended
September 30, 2009, we have a contractual guarantee to receive a minimum of $5.0
million in net proceeds, which significantly reduces the risk associated with
these initial investments. The majority of remaining acquisition
costs incurred are subject to contractual provisions providing for higher
percentage returns to our operating subsidiaries early on in the licensing and
enforcement program until such initial upfront acquisition costs are fully
recovered.
The
higher level of acquisition costs incurred in the current quarter reflects our
continued identification of opportunities to partner with major technology
companies and exchange up front, advanced royalty payments to patent owners, for
a reduced future inventor royalty percentage, resulting in the potential for
higher returns on our investments in connection with future licensing and
enforcement activities.
Acquisitions
during the nine months ended September 30, 2009 included the acquisition of, or
the acquisition of the rights to, 22 patent portfolios covering a variety of
applications, including the following:
|
·
|
Online
Promotion. This patented technology generally relates to
online promotion of consumer products and can be used to provide consumers
with web access to discount coupons and rebate
offers.
|
|
·
|
Interactive
Mapping. This patented technology generally relates to
interactive maps and can be used to provide user-generated data, such as
places of interest or reviews, over the
Internet.
|
|
·
|
Improved Anti-Trap
Safety. This patented technology can be used to adapt automatic
vent closure to changes, such as environment or mechanical wear. This
technology may be applicable to vehicles that implement
anti-pinch/anti-trap safety systems on powered vents such as windows,
doors and sunroofs.
|
|
·
|
Improved Commercial
Print. This patented technology can eliminate various print
artifacts while improving resolution, color and ink consumption from
commercial presses. Printers can benefit from these improvements,
particularly those who specialize in high volume press
work.
|
|
·
|
Electronic Securities Trading.
This patented technology generally relates to tools for automated
electronic securities trading and may be used in online
trading.
|
|
·
|
User Programmable Engine
Control. This patented technology generally relates to the user
interface for the engine control module (“ECM”) and offers control
and calibration of the ECM including input and output parameters
controlling engine performance.
|
|
·
|
Wireless LAN. This
patented technology generally relates to wireless local area networking
(“WLAN”) and includes communications architectures for use in spread
spectrum systems. This technology can be used in equipment
such as laptops, wireless routers, access points, handsets and other
consumer electronics devices with WLAN
capability.
|
|
·
|
Network Monitoring.
This patented technology generally relates to monitoring and reporting on
management and financial characteristics of networks and can be used
to help organizations make resource
decisions.
|
|
·
|
Medical Image
Manipulation. This patented technology generally relates to the
manipulation of medical images and can be used in the surgical
process.
|
|
·
|
Consumer Rewards
Program. This patented technology generally relates to
consumer rewards programs such as loyalty programs offered by
airlines, hotels and credit card companies and may be used
to provide a single source for consumers to
access and utilize applicable benefits under different
loyalty programs.
|
|
·
|
Messaging.
This patented technology generally relates to a communications
messaging platform that notifies the
user after receiving messages and enables the user
to access the messages via a
browser. The platform may receive messages in
multiple formats, such as voice, text, or
image.
|
|
·
|
Computer Architecture and
Power Management. These patented technologies generally relate
to computer architecture and power management. These
technologies can be used in computers, servers, cell phones, game
consoles, microprocessors and other electronic
systems.
|
|
·
|
Records Management.
This patented technology generally relates
to enabling individuals in an enterprise to uniformly classify
records.
|
|
·
|
Digital Video
Enhancement. This patented technology generally relates to the
enhancement of digital video images and has applications in a wide
variety of consumer electronics products, such as TV’s, DVD/Blu-ray
players, game consoles, smart phones and cameras, in reducing
artifacts created during digital video
encoding.
|
|
·
|
Biosensor. This
patented technology generally relates to biosensors, such as those used in
drug discovery.
|
|
·
|
Integrated Access. This
patented technology includes the delivery of triple play (voice,
video and data) services and can be used in installations that
incorporate set top boxes and/or voice/data
gateways.
|
|
·
|
Mobile Computer
Synchronization. The patent portfolio includes patents
relating to the synchronization of data between mobile and fixed computer
systems. This technology may be used to keep email, contacts,
calendar information and other data synchronized between mobile
devices (such as PDA’s and smart phones) and servers or desktop
computers.
|
As of
September 30, 2009, certain of our operating subsidiaries had several option
agreements with third-party patent portfolio owners regarding the potential
acquisition of additional patent portfolios. Future patent portfolio
acquisitions will continue to expand and diversify our future revenue generating
opportunities.
Critical
Accounting Estimates
Our
unaudited interim financial statements have been prepared in accordance with
accounting principles generally accepted in the United States of America.
Preparation of these statements requires management to make judgments and
estimates. Some accounting policies have a significant impact on amounts
reported in these financial statements. A summary of significant accounting
policies and a description of accounting policies that are considered critical
may be found in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2008, filed with the SEC on February 26, 2009, in the Notes to the
Consolidated Financial Statements and the Critical Accounting Estimates
section. In addition, refer to Note 2 to the Consolidated Financial
Statements included in this report.
Comparison
of the Results of Operations for the Three and Nine Months Ended September 30,
2009 and 2008
Net
Loss Attributable to Acacia Research Corporation (In thousands)
|
|
For
the Three Months Ended
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss attributable to Acacia Research Corporation
|
|
$ |
(4,775 |
) |
|
$ |
(2,420 |
) |
|
$ |
(9,780 |
) |
|
$ |
(11,950 |
) |
The
changes in net loss were primarily due to the operating results and activities
for the periods presented as discussed below.
Revenue
(In thousands)
|
|
For
the Three Months Ended
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
License
fees
|
|
$ |
12,831 |
|
|
$ |
13,796 |
|
|
$ |
40,512 |
|
|
$ |
29,960 |
|
License Fees. Revenues for
the three months ended September 30, 2009 included license fees from 36 new
licensing agreements covering 18 of our technology licensing and enforcement
programs, as compared to 20 new licensing agreements covering 18 of our
technology licensing and enforcement programs during the three months ended
September 30, 2008. Two licensees accounted for
25% and 23% of license fee revenues recognized during the three months ended
September 30, 2009, and two licensees accounted for
43% and 11% of license fee revenues recognized during the three months ended
September 30, 2008.
Revenues
for the nine months ended September 30, 2009 included license fees from 85 new
licensing agreements covering 25 of our technology licensing and enforcement
programs, as compared to 60 new licensing agreements covering 24 of our
technology licensing and enforcement programs during the nine months ended
September 30, 2008. One
licensee accounted for 12% of license fee revenues recognized during the nine
months ended September 30, 2009, and one licensee accounted for
20% of license fee revenues recognized during the nine months ended September
30, 2008.
The 7%
decrease in license fee revenues for the three month periods presented was due
to a decrease in the average revenue per license agreement executed during the
three months ended September 30, 2009, as compared to the three months ended
September 30, 2008, which was partially offset by an increase in the number of
new licensing agreements executed during the same periods. The 35%
increase in license fee revenues for the nine month periods presented was due to
an increase in the number of license agreements executed during the nine months
ended September 30, 2009, as compared to the nine months ended September 30,
2008, which was partially offset by a decrease in the average revenue per
license agreement executed during the same periods. License fee
revenues recognized by our operating subsidiaries fluctuate from period to
period primarily based on the following factors:
|
·
|
the
dollar amount of agreements executed each period, which is primarily
driven by the nature and characteristics of the technology being licensed
and the magnitude of infringement associated with a specific
licensee;
|
|
·
|
the
specific terms and conditions of agreements executed each period and the
periods of infringement contemplated by the respective
payments;
|
|
·
|
fluctuations
in the total number of agreements
executed;
|
|
·
|
fluctuations
in the sales results or other royalty per unit activities of our licensees
that impact the calculation of license fees
due;
|
|
·
|
the
timing of the receipt of periodic license fee payments and/or reports from
licensees; and
|
|
·
|
fluctuations
in the net number of active licensees period to
period.
|
Deferred
license fee revenues, representing upfront license fee payments received or
receivable from licensees at the beginning of the contractual license term,
which are deferred and amortized in the statement of operations as license fee
revenues on a straight-line basis over the applicable license term, increased to
$7.0 million at September 30, 2009, compared to $318,000 at December 31,
2008. Related deferred royalties and contingent legal fees expense,
which are also amortized in the statements of operations on a straight-line
basis over the applicable license term, totaled $3.8 million at September 30,
2009. The noncurrent portion of deferred royalties and contingent
legal fees, totaling $1,413,000 is included in “Other assets –
noncurrent.”
Operating
Costs and Expenses and Net Income Attributable to Noncontrolling Interests (In
thousands)
|
|
For
the Three Months Ended
|
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inventor
royalties
|
|
$ |
3,010 |
|
|
$ |
4,329 |
|
|
$ |
8,890 |
|
|
$ |
8,596 |
|
Contingent
legal fees
|
|
|
3,470 |
|
|
|
3,934 |
|
|
|
9,890 |
|
|
|
8,503 |
|
Legal
expenses - patents
|
|
|
3,536 |
|
|
|
1,110 |
|
|
|
7,000 |
|
|
|
3,111 |
|
Research,
consulting and other expenses
|
|
|
404 |
|
|
|
444 |
|
|
|
1,350 |
|
|
|
1,555 |
|
Amortization
of patents
|
|
|
1,245 |
|
|
|
1,152 |
|
|
|
3,370 |
|
|
|
3,731 |
|
Marketing,
general and administrative expenses (including non-cash stock compensation
expense
of $1,472 and $5,573 for the three and nine months ended September 30,
2009, respectively
and $1,949 and $5,716 for the three and nine months ended September
30, 2008, respectively)
|
|
|
5,089 |
|
|
|
5,464 |
|
|
|
17,076 |
|
|
|
17,014 |
|
Net
income attributable to noncontrolling interests in operating
subsidiary
|
|
|
1,029 |
|
|
|
- |
|
|
|
3,150 |
|
|
|
- |
|
Inventor Royalties, Net Income
Attributable to Noncontrolling Interests in Operating Subsidiary and Contingent
Legal Fees Expense. Net income attributable to noncontrolling
interests in operating subsidiary, represents the portion of net proceeds from
the licensing and enforcement activities of our majority-owned operating
subsidiary that are distributable to the operating subsidiary’s noncontrolling
interest holders pursuant to the underlying operating agreement. The
economic terms of the inventor agreements, operating agreements and contingent
legal fee arrangements, if any, including royalty rates, contingent fee rates
and other terms, vary across the patent portfolios owned or controlled by our
operating subsidiaries. As such, inventor royalties, other payments
to patent owners and contingent legal fees expenses fluctuate period to period,
based on the amount of revenues recognized each period and the mix of specific
patent portfolios with varying economic terms generating revenues each
period.
In the
aggregate, inventor royalties and noncontrolling interests in operating
subsidiaries decreased 7% and increased 40%, respectively, during the three and
nine months ended September 30, 2009, as compared to a 7% decrease and a 35%
increase, respectively, in license fee revenues for the same
periods. Contingent legal fee expenses decreased 12% and increased
16%, respectively, during the three and nine months ended September 30, 2009,
due to certain patent portfolios with lower contingent fee rates generating
revenues during the three and nine months ended September 30, 2009, as compared
to the patent portfolios generating revenues during the three and nine months
ended September 30, 2008.
Legal Expense –
Patents. Patent-related legal expenses include patent-related
prosecution and enforcement costs incurred by outside law firms engaged on an
hourly basis and the out-of-pocket expenses incurred by law firms engaged on a
contingent fee basis. Patent-related legal expenses fluctuate from
period to period based on patent enforcement and prosecution activity associated
with ongoing licensing and enforcement programs and the timing of the
commencement of new licensing and enforcement programs in each
period. The net increase during the three and nine months ended
September 30, 2009, as compared to the three and nine months ended September 30,
2008, is primarily due to an increase in litigation support related out of
pocket expenses, third party technical consulting expenses and professional
expert expenses incurred in connection with our continued investment in certain
of our licensing and enforcement programs with trial dates scheduled for late
2009 and early 2010, and a net increase in costs related to new licensing and
enforcement programs commenced since the end of the prior year
period. We expect patent-related legal expenses to continue to
fluctuate period to period based on the factors summarized above, in connection
with upcoming scheduled trial dates and our current and future patent
acquisition, development, licensing and enforcement activities.
Research, Consulting and Other
Expenses - Patents. Research, consulting and other expenses
include third-party licensing and enforcement related research, development,
consulting, and patent maintenance costs incurred in connection with the
licensing and enforcement of patent portfolios. These costs fluctuate
period to period based on patent-related licensing and enforcement activities in
each period. The decrease during the three and nine months ended
September 30, 2009, as compared to the three and nine months ended September 30,
2008, is due to normal fluctuations in related licensing and enforcement
activities. We expect patent-related research, consulting and other
expenses to continue to fluctuate period to period based on the factors
summarized above, in connection with our current and future patent-related
licensing and enforcement activities.
Marketing, General and
Administrative Expenses. Marketing, general and administrative
expenses include employee compensation and related personnel costs, including
non-cash stock compensation expenses, office and facilities costs, legal and
accounting professional fees, business development related research and
consulting costs, public relations, marketing, stock administration and other
corporate costs.
A summary of the main drivers of the
change in marketing, general and administrative expenses, including the impact
of non-cash stock compensation charges, for the periods presented, is as follows
(in thousands):
|
|
For
the Three Months Ended
September 30, 2009 vs.
2008
|
|
|
For
the Nine
Months Ended September
30, 2009 vs.
2008
|
|
|
|
|
|
|
|
|
Business
development related research and consulting costs
|
|
|
153 |
|
|
|
461 |
|
One
time employee severance charges
|
|
|
- |
|
|
|
(68 |
) |
Corporate,
general and administrative costs
|
|
|
(51 |
) |
|
|
(188 |
) |
Non-cash
stock compensation expense
|
|
|
(477 |
) |
|
|
(143 |
) |
Other
As a
result of the analysis of certain auction rate securities collateralized by
student loan portfolios, as described at Note 7 to the Consolidated Financial
Statements included in this report, we recorded an other-than-temporary loss of
$263,000 in the accompanying statement of operations for the nine months ended
September 30, 2008. As of September 30, 2009, the net
other-than-temporary loss on auction rate securities collateralized by student
loan portfolios totaled $237,000.
As a
result of the analysis of certain auction rate securities issued by high credit
quality closed-end investment companies, as described at Note 7 to the
Consolidated Financial Statements included in this report, we recorded an
other-than-temporary loss on auction rate securities issued by high credit
quality closed-end investment companies of $236,000 in the statement of
operations for the three months ended December 31, 2008. As of
September 30, 2009, the net other-than-temporary loss on auction rate securities
issued by high credit quality closed-end investment companies totaled
$14,000.
As a
result of partial redemptions at par on certain of these auction rate
securities, we recorded realized gains totaling $201,000 and $235,000 for the
three and nine months ended September 30, 2009, respectively, and $13,000 for
the three and nine months ended September 30, 2008, reflecting a partial
recovery of the other-than-temporary loss originally recorded on these
securities.
Inflation
Inflation
has not had a significant impact on us.
Liquidity
and Capital Resources
General
Our
primary sources of liquidity are cash and cash equivalents and investments, as
well as cash generated from operations. Our management believes that
the cash and cash equivalent balances, investments, anticipated cash flow from
operations and other external sources of available credit, will be sufficient to
meet our cash requirements through at least November 2010 and for the
foreseeable future. We may however encounter unforeseen difficulties that may
deplete our capital resources more rapidly than anticipated, including those set
forth under the caption “Risk Factors” beginning on page 6 of our Annual Report
on Form 10-K for the year ended December 31, 2008, filed with the SEC on
February 26, 2009. Any efforts to seek additional funding could be made through
equity, debt or other external financing. However, additional funding
may not be available on favorable terms, or at all. The capital and credit
markets have been experiencing extreme volatility and disruption for more than
12 months. Recently, the volatility and disruption have reached unprecedented
levels. In several cases, the markets have exerted downward pressure on stock
prices and credit capacity for certain issuers, and there can be no assurance
that the commercial paper markets will be a reliable source of short-term
financing for us. If we fail to obtain additional funding when needed, we may
not be able to execute our business plans and our business may
suffer.
Cash
and Investments
Our
consolidated cash and cash equivalents and investments totaled
$45.3 million at September 30, 2009, compared to $51.5 million at
December 31, 2008. The net change in cash and cash equivalents
for the periods presented was comprised of the following (in
thousands):
|
|
For
the Nine Months Ended
|
|
|
|
September
30, 2009
|
|
|
September
30, 2008
|
|
Net
cash provided by (used in):
|
|
|
|
|
|
|
Operating
activities
|
|
$ |
5,896 |
|
|
$ |
(4,175 |
) |
Investing
activities
|
|
|
(8,232 |
) |
|
|
4,276 |
|
Financing
activities
|
|
|
(3,143 |
) |
|
|
142 |
|
Cash Flows from Operating
Activities. Cash receipts from licensees for the nine months
ended September 30, 2009 increased to $48.1 million, from $21.0 million in the
comparable 2008 period, due to an increase in license fee revenues for the nine
months ended September 30, 2009, as compared to the nine months ended September
30, 2008, and cash collections related to the December 31, 2008 balance of
accounts receivable from licensees during the nine months ended September 30,
2009. Cash receipts from licensees for the nine months
ended September 30, 2008 does not reflect $10.5 million in accounts receivable
from licensees reflected in the September 30, 2008 balance sheet, the majority
of which was received from licensees in the fourth quarter of 2008.
Cash
outflows from operations for the nine months ended September 30, 2009 increased
to $42.2 million, as compared to $25.2 million in the comparable 2008 period,
due to the net increase in operating costs and expenses, as discussed above, and
the impact of the timing of payments to inventors, attorneys and other
vendors.
Cash Flows from Investing
Activities. The change in net cash flows used in investing activities was
primarily due to patent portfolio acquisitions and net sales of
available-for-sale investments in connection with ongoing short-term cash
management activities during the periods presented. Net cash outflows
from investing activities for the nine months ended September 30, 2009 included
patent-related acquisition costs totaling $9.2 million, as compared to $1.8
million in the comparable 2008 period. Refer to the “Overview”
section above for a discussion of patent acquisition activities for the periods
presented. Net sales of short-term investments for the nine months
ended September 30, 2009 totaled $990,000, as compared to $6.1 million in the
comparable 2008 period.
Cash Flows from Financing
Activities. In May 2009, our board of directors approved a
restricted stock vesting net issuance program. Under the program,
upon the vesting of unvested shares of restricted common stock, we withheld from
fully vested shares of common stock otherwise deliverable to any
employee-participant in our equity compensation programs, a number of whole
shares of common stock having a fair market value (as determined by us as of the
date of vesting) equal to the amount of tax required to be withheld by law, in
order to satisfy the tax withholding obligations of ours in connection with the
vesting of such shares. Of a total of 580,600 shares of restricted
stock vesting from June to September 2009, 174,628 shares of common stock were
withheld by us, in satisfaction of $1,107,000 in required withholding tax
liability. Net cash flows provided by financing activities during the
nine months ended September 30, 2009 included proceeds from the exercise of
common stock options totaling $85,000 as compared to $142,000 in the comparable
2008 period.
Working
Capital
The
primary components of working capital are cash and cash equivalents, accounts
receivable, prepaid expenses, the current portion of deferred costs, accounts
payable, accrued expenses, royalties and contingent legal fees payable and the
current portion of deferred revenues. Working capital at September
30, 2009 was $34.2 million, compared to $42.6 million at December 31,
2008. Refer to “Liquidity and Capital Resources - Cash and
Investments” above for a discussion of the impact of activities related to cash
and investments on working capital for the periods presented.
Consolidated
accounts receivable from licensees decreased to $6.5 million at September 30,
2009, compared to $7.4 million at December 31, 2008. $4.0 million of
the September 30, 2009 balance in accounts receivable related to amounts
recorded as deferred revenues at September 30, 2009. Accounts
receivable balances fluctuate based on the timing, magnitude and payment terms
associated with license agreements executed during the period, and the timing of
cash receipts on accounts receivable balances recorded in previous
periods.
Consolidated
royalties and contingent legal fees payable decreased to $8.7 million at
September 30, 2009, compared to $10.8 million at December 31,
2008. Royalties and contingent legal fees payable balances fluctuate
based on the magnitude and timing of the execution of related license
agreements, the timing of cash receipts for the related license agreements, and
the timing of payment of current and prior period royalties and contingent legal
fees payable to inventor and outside attorneys, respectively.
The
majority of accounts receivable from licensees at September 30, 2009 were
collected or scheduled to be collected in the fourth quarter of 2009 and first
quarter of 2010, in accordance with the terms of the related underlying license
agreements. The majority of royalties and contingent legal fees
payable are scheduled to be paid in the fourth quarter of 2009 and first quarter
of 2010, upon receipt by us of the related license fee payments from licensees,
in accordance with the underlying contractual
arrangements.
Accounts
payable and accrued expenses increased to $5.8 million at September 30, 2009,
from $3.2 million at December 31, 2008, due primarily to the increase in
patent-related legal expenses and the related timing of payments to attorneys
and other vendors.
Deferred
license fee revenues, representing upfront license fee payments received or
receivable from licensees at the beginning of the contractual license term,
which are deferred and amortized in the statements of operations as license fee
revenues on a straight-line basis over the applicable license term, increased to
$7.0 million at September 30, 2009, compared to $318,000 at December 31,
2008. $4.0 million of the September 30, 2009 balance of total
consolidated deferred revenues related to amounts recorded as accounts
receivable at September 30, 2009. Deferred royalties and contingent
legal fees expense, which are also amortized in the statements of operations on
a straight-line basis over the applicable license term, totaled $3.8 million at
September 30, 2009. The noncurrent portion of deferred royalties and
contingent legal fees, totaling $1.4 million is included in “Other assets –
noncurrent.
Off-Balance
Sheet Arrangements
We have
not entered into off-balance sheet financing arrangements, other than operating
leases. We have no significant commitments for capital expenditures
in 2009. We have no committed lines of credit or other committed
funding or long-term debt. The following table lists our material
known future cash commitments as of September 30, 2009:
|
|
Payments
Due by Period (In thousands) |
|
Contractual
Obligations
|
|
Total
|
|
|
Less
than
1
year
|
|
|
1-3
years
|
|
|
3-5
years
|
|
|
More
than
5
years
|
|
Operating
leases
|
|
$ |
2,242 |
|
|
$ |
155 |
|
|
$ |
1,923 |
|
|
$ |
164 |
|
|
$ |
- |
|
Total
contractual obligations
|
|
$ |
2,242 |
|
|
$ |
155 |
|
|
$ |
1,923 |
|
|
$ |
164 |
|
|
$ |
- |
|
FIN 48
Liability. As of September 30, 2009, the liability for
uncertain tax positions, associated primarily with state income taxes, was
$75,000, of which none is expected to be paid within one year. The liability for
uncertain tax positions is recorded in other long-term liabilities in the
consolidated balance sheets.
Recent
Accounting Pronouncements
Refer to
Note 2 and Note 10 to the Consolidated Financial Statements included in
this report.
Item
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
The
primary objective of our investment activities is to preserve principal while
concurrently maximizing the income we receive from our investments without
significantly increasing risk. Some of the securities that we may invest in may
be subject to market risk. This means that a change in prevailing interest rates
may cause the principal amount of the investment to fluctuate. For example, if
we hold a security that was issued with a fixed interest rate at the
then-prevailing rate and the prevailing interest rate later rises, the current
value of the principal amount of our investment will decline. To minimize this
risk in the future, we intend to maintain our portfolio of cash equivalents and
short-term investments in a variety of securities, including commercial paper,
money market funds, high-grade corporate bonds, government and non-government
debt securities and certificates of deposit. In general, money market funds are
not subject to market risk because the interest paid on such funds fluctuates
with the prevailing interest rate. As of September 30, 2009, our investments
were comprised of money market funds and auction rate securities. A hypothetical
100 basis point increase in interest rates would not have a material impact on
the fair value of our available-for-sale securities as of September 30,
2009. Refer to “Liquidity and Capital Resources” and Note 7 to the
Consolidated Financial Statements included in this report for additional
information.
Item
4. CONTROLS AND PROCEDURES
Evaluation
of Disclosure Controls and Procedures
Our
management, with the participation and under the supervision of our chief
executive officer and chief financial officer, has evaluated the effectiveness
of our disclosure controls and procedures (as defined in Rule 13a-15(e)
promulgated under the Securities Exchange Act of 1934, as amended, or the
Exchange Act) as of the end of the period covered by this quarterly report.
Based on this evaluation, our chief executive officer and our chief financial
officer have concluded that, as of the end of the period covered by this
quarterly report, our disclosure controls and procedures were effective to
ensure that the information required to be disclosed by us in the reports that
we file or submit under the Exchange Act is accumulated and communicated to
management, including our chief executive officer and chief financial officer,
to allow timely decisions regarding required disclosure, and that such
information is recorded, processed, summarized and reported within the time
periods prescribed by the SEC.
Changes
in Internal Control Over Financial Reporting
There
were no changes in our internal control over financial reporting that occurred
during our last fiscal quarter (the quarter ended September 30, 2009) that have
materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.
PART
II--OTHER INFORMATION
Item
6. EXHIBITS
31.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
32.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
32.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
___________________
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
ACACIA
RESEARCH CORPORATION
|
|
|
|
|
|
By: /s/ Paul R.
Ryan
|
|
Paul
R. Ryan
|
|
Chief
Executive Officer
|
|
|
|
|
|
|
|
By: /s/ Clayton
J.
Haynes
|
|
Clayton
J. Haynes
|
|
Chief
Financial Officer and Treasurer
|
Date: November
4, 2009
EXHIBIT
INDEX
EXHIBIT
NUMBER
|
EXHIBIT
|
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) of the
Securities Exchange Act of 1934
|
32.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
32.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(b)/15d-14(b) of the
Securities Exchange Act of 1934 and 18 U.S.C. Section
1350
|
___________________
23